HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lepromatous Leprosy

A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.
Also Known As:
Leprosy, Lepromatous; Cutaneous Leprosies; Cutaneous Leprosy; Lepromatous Leprosies; Leprosies, Cutaneous; Leprosies, Lepromatous; Leprosies, Nodular; Nodular Leprosies; Nodular Leprosy; Leprosy, Cutaneous; Leprosy, Nodular
Networked: 1043 relevant articles (24 outcomes, 105 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Leprosy (Hansen's Disease)
2. Hypersensitivity (Allergy)
3. Erythema Nodosum
4. Multibacillary Leprosy
5. Tuberculosis (Tuberculoses)

Experts

1. Dogra, Sunil: 6 articles (01/2021 - 06/2005)
2. Sarno, Euzenir N: 6 articles (01/2016 - 02/2010)
3. Narang, Tarun: 5 articles (01/2021 - 06/2005)
4. Modlin, Robert L: 5 articles (05/2020 - 03/2005)
5. Khanna, Neena: 5 articles (01/2020 - 11/2003)
6. Brennan, Patrick J: 5 articles (02/2013 - 03/2005)
7. Ramesh, V: 5 articles (01/2013 - 12/2000)
8. Ochoa, Maria T: 4 articles (05/2020 - 02/2010)
9. Saini, Chaman: 4 articles (01/2020 - 01/2013)
10. Quaresma, Juarez Antonio Simões: 4 articles (01/2018 - 01/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lepromatous Leprosy:
1. VaccinesIBA
2. DapsoneFDA Link
3. Immunoglobulin M (IgM)IBA
4. Rifampin (Rifampicin)FDA LinkGeneric
5. Clofazimine (Lamprene)FDA Link
6. Thalidomide (Thalomid)FDA Link
7. AntibodiesIBA
8. Immunoglobulin G (IgG)IBA
9. Levamisole (Decaris)FDA Link
10. LeprominIBA

Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Immunotherapy
4. Aftercare (After-Treatment)
5. Lasers (Laser)